Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00732 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Xiaofei Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Basic Medical Research, Medical School of Nantong University, Nantong 226001, P. R. China. Hauptthemen laut MEDLINE: Morphine, Analgesics, Opioid, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: ?333 Project? of Jiangsu Province, High Level Innovation and Entrepreneurial Research Team Program in Jiangsu, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic pain is a debilitating disease and remains challenging to treat. Morphine serves as the most commonly used drug for the treatment of pathological pain. However, detrimental side effects (e.g., hyperalgesia and tolerance) manifest during chronic administration, thus counteracting morphine analgesia. Investigators have sought methods to widen the therapeutic window of morphine in the management of chronic pain. Programmed cell death protein 1 (PD-1) is a recently validated analgesic target and is coexpressed with the mu opioid receptor (μOR) in dorsal root ganglion (DRG) sensory neurons. Here, we present evidence that PD-1 regulates the expression of μOR mRNA and influences μOR-mediated analgesia. Notably, the concomitant administration of PD-1 agonist H-20 greatly reduces the dosage of morphine needed for analgesia, thereby significantly decreasing opioid-related side effects. This new combination therapy may provide a solution for managing chronic pain in patients who require morphine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Basic Medical Research, Medical School of Nantong University, Nantong 226001, P. R. China.
- Department of Histology and Embryology, Medical School of Nantong University, Nantong 226001, P. R. China.
- Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong 226001, P. R. China.
ORCID-Profile: Long Zhao
Förderung
- ?333 Project? of Jiangsu Province
- High Level Innovation and Entrepreneurial Research Team Program in Jiangsu
- National Natural Science Foundation of China
Zitieren
APA
Song, X., Zhang, Y., Liu, Y., Chen, G., & Zhao, L. (2025). Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00732
Vancouver
Song X, Zhang Y, Liu Y, Chen G, Zhao L. Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00732
BibTeX
@article{Song2025,
author = {Song, Xiaofei and Zhang, Ying and Liu, Yuxin and Chen, Gang and Zhao, Long},
title = {Enhanced Analgesic Efficacy and Reduced Side Effects of Morphine by Combination with PD-1 Agonist},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00732}
}
EUVIMED